Navigation Links
Focus on dementia
Date:10/15/2010

Alzheimer's disease is not the only type of dementia. Two particular forms are dementia with Lewy bodies and Parkinson's disease dementia. In both forms, the diagnosis is of vital importance because the treatment for these dementias differs from that for Alzheimer's dementia, as Brit Mollenhauer and co-authors explain in the dementia theme issue of Deutsches rzteblatt International (Dtsch Arztebl Int 2010; 107[39]: 684-91).

In more than 75% of patients, the memory impairments are due to Alzheimer's disease. In Lewy body dementia, which is accompanied by cognitive and/or further psychiatric symptoms, and in Parkinson's disease dementia, these develop only after the motor symptoms of the disorder have fully developed.

Gerhard Eschweiler and co-authors (Dtsch Arztebl Int 2010; 107[39]: 677-83) in their article introduce biomarkers that raise the probability of identifying Alzheimer's disease at the stage of mild cognitive impairment and up to five years before full-blown dementia to 80%.

Richard Mahlberg in an introductory editorial emphasizes that the attempts to find an exact differential diagnosis are not merely academic exercises, but that new developments of diagnosis-specific, differentiated interventions for the future depend crucially on a correct initial diagnosis.


'/>"/>

Contact: Brit Mollenhauer
Brit.mollenhauer@pk-mx.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Front of Food Labels Should Focus on Calories, Salt, Fats: Report
2. The Ross Summit to focus on new survival data, technique refinement and availability
3. Study focuses on mephedrone use in Northern Ireland post-ban
4. SNM sharpens focus on molecular imaging innovation and translation
5. Health information technology is focus of AAP symposium
6. International conference focusing on womens mental health Oct. 27 to 30 in Pittsburgh
7. Cant focus? Maybe its the wrong time of month
8. Latent HIV infection focus of NIDAs 2010 Avant-Garde Award
9. American Chemical Society Webinar focuses on NSFs small business funding programs
10. St. Jude researcher receives grant to focus on cancer pharmacogenomics in children
11. American Chemical Society Webinar focuses on providing scientific advice to the film industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 10, 2016 , ... Everseat has joined the award-winning Allscripts ... physicians. The integration will enable Allscripts users to post open appointments to the ... app. , The partnership gives Everseat substantial added power to help Allscripts meet ...
(Date:2/10/2016)... ... 10, 2016 , ... Workrite Ergonomics this week announced the launch of the ... , “Our goal was to develop a product from the ground up that ... ever created.” said Darren Hulsey, Product Manager for Workrite Ergonomics. “The Conform series ...
(Date:2/10/2016)... ... February 10, 2016 , ... Anxiety of older Americans over steep cost increases ... D a decade ago, according to The Senior Citizens League (TSCL). ... are coping with rapidly rising costs. “The implications are chilling, particularly for people ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Body Specialists are delighted to welcome a new addition to their growing practice. ... Body Specialists as a nurse practitioner performing cosmetic procedures including injectables, ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... It’s that ... Traci Davis, the new president of the Interscholastic Athletic Association of Maryland (IAAM), Hall ... well how quickly fitness goals are cast aside. , That’s why one of her ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... Florida , February 9, 2016 ... today announced a collaboration with 10x Genomics to ... (NGS), single-cell biology and bioinformatics. --> ... a collaboration with 10x Genomics to develop and ... biology and bioinformatics. --> QIAGEN N.V. ...
(Date:2/9/2016)... , Feb. 9, 2016 Mast Therapeutics, ... clinical-stage therapies for sickle cell disease and heart failure, today ... and warrants to purchase common stock in an underwritten public ... and there can be no assurance as to whether or ... actual size or terms of the offering.   ...
Breaking Medicine Technology: